More about

Endometrial Cancer

News
March 22, 2022
2 min read
Save

FDA approves Keytruda for advanced endometrial carcinoma subset

FDA approves Keytruda for advanced endometrial carcinoma subset

The FDA approved pembrolizumab for certain women with microsatellite instability-high or mismatch repair-deficient advanced endometrial cancer.

News
March 16, 2022
2 min read
Save

32% of older women who survived certain cancers report lower extremity lymphedema

32% of older women who survived certain cancers report lower extremity lymphedema

Nearly one-third of older women who survived colorectal, endometrial or ovarian cancer reported lower extremity lymphedema, according to data published in JAMA Network Open.

News
February 10, 2022
1 min read
Save

Selinexor extends PFS in advanced endometrial cancer

Selinexor extends PFS in advanced endometrial cancer

Selinexor prolonged PFS compared with placebo among women with advanced or recurrent endometrial cancer, according to topline data released by the agent’s manufacturer.

News
February 07, 2022
2 min read
Save

Lenvatinib plus pembrolizumab improves survival outcomes in advanced endometrial cancer

Lenvatinib plus pembrolizumab improves survival outcomes in advanced endometrial cancer

Lenvatinib plus pembrolizumab conferred significantly longer PFS and OS than chemotherapy among women with advanced endometrial cancer, according to randomized, phase 3 trial results published in The New England Journal of Medicine.

News
January 31, 2022
2 min read
Save

Pembrolizumab shows durable activity in subset of women with endometrial cancer

Pembrolizumab shows durable activity in subset of women with endometrial cancer

Pembrolizumab showed strong and lasting antitumor activity in women with previously treated, advanced microsatellite instability-high or mismatch repair-deficient endometrial cancer, according to a study in Journal of Clinical Oncology.

News
January 21, 2022
2 min read
Save

Coffee consumption may reduce endometrial cancer risk

Coffee consumption may reduce endometrial cancer risk

Coffee consumption may reduce the risk for endometrial cancer, according to a study published in The Journal of Obstetrics and Gynaecology Research.

News
October 18, 2021
2 min read
Save

Aromatase inhibitors may be beneficial in endometrial stromal sarcomas

In a study of patients with endometrial stromal sarcomas treated with aromatase inhibitors the objective response rate was more modest than expected, but a majority did achieve stable disease, according to a study presented at the ASCO Annual Meeting.

News
August 10, 2021
1 min read
Save

FDA grants priority review to Keytruda for renal cell carcinoma subset

FDA grants priority review to Keytruda for renal cell carcinoma subset

The FDA granted priority review to pembrolizumab as adjuvant therapy for certain patients with renal cell carcinoma, according to the agent’s manufacturer.

News
July 28, 2021
3 min read
Save

Screening method frequently misses endometrial cancer in Black women

Screening method frequently misses endometrial cancer in Black women

Transvaginal ultrasound used to determine appropriateness of endometrial cancer biopsy missed nearly five times more cases of the disease among Black women vs. white women, according to a simulated cohort study published in JAMA Oncology.

News
July 22, 2021
2 min watch
Save

VIDEO: Less intense follow-up adequate in endometrial cancer

VIDEO: Less intense follow-up adequate in endometrial cancer

In this video, Christina M. Annunziata, MD, PhD, senior investigator at the National Cancer Institute, discussed results from the TOTEM trial presented at the ASCO Annual Meeting.

View more